The following chart is a section-by-section summary of the MCED legislation, comparing the legislation introduced in the 118th Congress with the version introduced in the 119th Congress.
On Thursday, January 23, 2026, the House passed the Consolidated Appropriations Act of 2026, which included the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
ACS CAN joined with 50 other organizations to applaud Representatives Jodey Arrington (R-TX) and Terri Sewell (D-AL) for sponsoring and prioritizing the passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842).
Multi-Cancer Early Detection Tests (MCEDs) are simple blood tests that can screen for many types of cancer at once. Congress must seize the opportunity to ensure these cutting-edge tests can be covered under Medicare once they are FDA-approved and proven to have clinical benefit. Doing so has the potential to save lives and revolutionize the way we detect cancer.
